Keiretsu Capital

Keiretsu Capital, founded in 2013 and headquartered in Seattle, Washington, is a venture capital firm that specializes in early-stage investments across various sectors, including life sciences, healthcare, technology, real estate, cleantech, fintech, and blockchain. The firm leverages its affiliation with the Keiretsu Forum, one of the world's largest angel investor networks, to access proprietary deal flow and enhance the value of investments. Keiretsu Capital assists in presenting portfolio companies to a range of investors, such as syndicate partners and venture capitalists, aiming for significant capital appreciation through strategic investments in high-quality emerging companies. The firm also operates co-investment funds, further diversifying its investment strategy and fostering collaboration within the investment community.

Nathan McDonald

CEO and Managing Partner

Clinton Pinto

Managing Director

106 past transactions

Levered Learning

Venture Round in 2021
Levered Learning is an instructional system focused on enhancing mathematical education for students in grades 3 to 5. Founded in 2017 and based in Soquel, California, the company offers a web-based platform that combines whole-class discussions, collaborative pencil-and-paper exercises, and self-paced online lessons. This system is designed to support both classroom and distance learning, helping teachers address learning gaps while promoting student growth in mathematics. By integrating various teaching methods, Levered Learning aims to improve educational outcomes for elementary students.

Tend Health

Venture Round in 2021
Tend Health is a company that focuses on developing fecal microbiota transplant solutions aimed at restoring patients' healthy intestinal microbiomes. Based in Seattle, Washington, the company offers clinicians a non-invasive method to enhance gut health through innovative devices that process stool samples into capsules or suppositories. Founded in 2020, Tend Health emphasizes personalized data and insights, enabling patients to take control of their gastrointestinal well-being.

Pattern Computer

Venture Round in 2021
Pattern Computer, Inc. is a pattern discovery company based in Friday Harbor, Washington, that specializes in uncovering insights from complex datasets. Founded in 2016, the company has developed a proprietary system that generates hypotheses and insights, enabling clients to tackle challenging problems in fields such as medical research and business analytics. Its platform is particularly noted for its application in breast cancer prognostics and the differentiation of healthy and disease-state pathways in microbiome and human gut disorders. By utilizing advanced techniques that surpass conventional methods, Pattern Computer aims to reveal novel patterns that can drive innovation and improve industry standards.

Healionics

Venture Round in 2021
Healionics Corporation, based in Seattle, Washington, specializes in the development and manufacture of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created the STARport HD, an implantable device that enables needle-free bloodstream access for hemodialysis, and the STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without the complications associated with traditional grafts. Healionics' innovative approach addresses critical challenges in dialysis treatment, such as the high costs and health risks associated with current vascular access methods. Their technology promises to enhance patient outcomes by reducing the need for costly interventions and minimizing complications like infection and scarring. With a robust patent portfolio and successful results from animal studies, Healionics is poised to begin human trials and further develop its product line, which includes additional applications for its STAR biomaterial in various medical devices.

Seneca Therapeutics

Venture Round in 2021
Seneca Therapeutics, Inc. is a biotechnology company based in Blue Bell, Pennsylvania, specializing in the development of oncolytic immunotherapeutics for cancer treatment. The company's primary product is the Seneca Valley Virus (SVV), an oncolytic virus designed to selectively replicate within and eliminate tumor cells. Seneca Therapeutics aims to advance SVV as a versatile therapeutic option, offering it in the form of cancer therapeutics, cancer vaccines, and vaccines for infectious diseases. Additionally, the company focuses on creating targeted biologics that can work in conjunction with immune checkpoint inhibitors and cancer vaccines, enhancing treatment efficacy and addressing immune tolerance in patients. Incorporated in 2018, Seneca Therapeutics is dedicated to providing innovative solutions for various types of cancer.

EternaTear

Series A in 2020
EternaTear, Inc. is focused on developing an innovative artificial tear solution aimed at addressing the challenges of dry eye syndrome. Based in Raleigh, North Carolina, the company has created EternaTear, a product designed to provide lubrication and therapeutic relief for individuals suffering from progressive dry eye. The solution utilizes a proprietary mechanism to supplement and bind the three layers of the tear film, enhancing stability and prolonging its presence on the ocular surface. This approach aims to mitigate the inadequate relief provided by existing over-the-counter options, which often require frequent reapplication and do not address the underlying causes of dry eye. By combining established technologies with novel research, EternaTear seeks to offer a more effective treatment that can significantly improve patients' quality of life and reduce symptoms associated with this condition.

Steelhead Composites

Venture Round in 2020
Steelhead Composites is an engineering and manufacturing company with full service, in house design, testing, prototyping and production of composite pressure vessels, hydrogen storage, seamless metal cylinders, composite structures and pressurant tanks. The advanced manufacturing process, fully digital shop floor, superb quality systems and design capabilities allow Steelhead to compete in niche hydraulic applications, aerospace applications and in the design and manufacturing of hydrogen storage options for fuel cells and vessels for containing compressed gasses.

LumiThera

Series C in 2020
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Established in 2013, the company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LED) and laser technologies to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. By employing low-level light therapy, LumiThera aims to slow or halt the progression of blinding diseases, enhance visual acuity and contrast sensitivity, and reduce central drusen volume, ultimately providing healthcare providers with effective treatment options for their patients.

Your Fare

Convertible Note in 2020
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

HaptX

Series A in 2019
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

Embera NeuroTherapeutics

Series B in 2019
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

PittMoss

Series B in 2019
PittMoss LLC manufactures an innovative growing media called PittMoss, which consists of organic additives and recycled paper, catering to commercial greenhouses, nurseries, and home gardeners across the United States. The company also produces PittMoss Prime, a versatile soil amendment that can be combined with compost, existing soil blends, or native soil. Founded in 1994 and based in Ambridge, Pennsylvania, PittMoss focuses on sustainability and environmental responsibility, aiming to enhance soil health and improve gardening outcomes. The company's products reflect extensive research and development in the fields of gardening and soil science, establishing a strong presence in the growing media market.

UnaliWear

Seed Round in 2019
UnaliWear Inc., based in Austin, Texas, develops the Kanega watch, a multipurpose wearable designed for seniors to maintain independence and dignity. This discreet device offers features such as fall detection, medication reminders, and assistance for individuals who may wander, all through a voice-activated interface. The Kanega watch is equipped with various technologies, including cellular, Wi-Fi, GPS, and Bluetooth, allowing it to provide emergency support anywhere without the need for a smartphone. Its patented battery system ensures that the watch remains charged without requiring removal. Additionally, the device incorporates data-driven artificial intelligence to learn the user’s lifestyle, enabling it to offer predictive and preemptive assistance tailored to individual needs.

Point of Choice

Venture Round in 2019
Point of Choice LLC develops cloud-based platform that streamlines the purchasing process of school district. It provides k-Purchase, software that ensures vendor product offerings, special pricing and promotions reach the right people in each school districts . The company was incorporated in 2015 and is based in Fairfield, Iowa.

Astarte Medical

Series A in 2019
Astarte Medical Partners, Inc. develops a software that provides a universal view of clinical data in real time to assess the state of the preterm infant’s gut health to make more informed decisions. The product enables NICU clinical care teams to standardize and streamline the practice of feeding. Astarte Medical Partners, Inc. was incorporated in 2016 and is based in Yardley, Pennsylvania.

Stor and Deliver

Venture Round in 2019
Stor and Deliver was founded to free you from the hassle of loading, hauling, and moving into storage. They provide full-service, concierge storage with a pickup at your door and on-demand return delivery for the cost of a traditional self-storage unit.

Turn Technologies

Venture Round in 2019
Turn Technologies, Inc. is a Chicago-based company that specializes in developing an online application for managing the workforce. Founded in 2016, it operates an AI-powered workforce-as-a-service platform that enables companies to efficiently source, screen, and retain contingent workers, especially in the gig economy. The platform is designed to streamline the hiring process, allowing businesses to quickly find qualified candidates and verify their credentials within hours. It features mobile-friendly services, seamless integration with existing HR systems, and tools for compliance, helping companies onboard workers smoothly while maintaining regulatory standards. By consolidating worker profiles and preferences, Turn Technologies enhances engagement and retention, ultimately reducing the costs associated with workforce acquisition.

Kokopelli Outdoor

Venture Round in 2019
Kokopelli Outdoor, Inc. is a manufacturer of packrafts and related gear, catering to outdoor enthusiasts seeking to explore nature's serene environments. Founded in 2014 and based in Denver, Colorado, the company not only produces packrafts but also organizes courses and events focused on packrafting. Additionally, Kokopelli Outdoor engages in online retail, offering its products directly to consumers.

Atrin Pharmaceuticals

Venture Round in 2019
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of innovative cancer treatments. Founded in 2011, the company specializes in proprietary medications, including ATRN-502, a p53 activator, and ATRN-507, a dual ligand that selectively targets cancer cells. Atrin's advanced research is centered on developing a new class of compounds that act as specific inhibitors of ATR, a crucial mediator in DNA repair. The company utilizes its proprietary screening platform, Atrize, which enables high-throughput evaluation of drug candidates and personalized medicine approaches. This platform allows for the rapid identification of compounds that effectively inhibit cancer cell viability while minimizing effects on healthy cells, thus advancing the potential for more effective cancer therapies.

InReality

Venture Round in 2018
InReality is a solution-as-a-service company that helps brands and retailers drive conversion and optimize in-store investments. Brands and retailers use our IoT-based customer experience solutions to drive in-store conversion of shoppers to sales. Companies leverage our platform to maximize the consumer journey across stores, categories, displays or merchandise. Through real-time analytics and responsive technology combined with insight, design and delivery services, we ensure success by optimizing return on marketing spend.

Virion Therapeutics

Series A in 2018
Virion Therapeutics, LLC, a biotechnology company, develops immune-based treatments for virally-associated cancers and chronic viral infections. It offers ChiVax and ChiVax-gD vaccines to induce potent and sustained T cell-mediated immune responses against transformed and infected cells. Virion Therapeutics, LLC was incorporated in 2018 and is based in Newark, Delaware.

SageMedic

Venture Round in 2018
SageMedic Corporation develops SAGE Direct Test, a medicine for the treatment of cancer patients. Its technology uses a biopsy of patient’s live cancer tissue to create biologically similar 3D micro-tumors in lab. The company was incorporated in 2017 and is based in Redwood City, California.

Toma Biosciences

Series C in 2018
TOMA Biosciences, Inc. develops reagent kits that enable laboratories and researchers to uncover genomic changes in tumors. The company offers TOMA OS-Seq, an oncology-focused gene analysis solution. It serves laboratories, hospital systems, and research institutions worldwide. The company was incorporated in 2011 and is based in Foster City, California.

RealKey

Funding Round in 2018
RealKey, Inc., established in 2015 and located in San Francisco, California, specializes in digital mortgage technologies aimed at enhancing the mortgage processing experience for both bank and non-bank mortgage loan originators (MLOs). The company's RealKey Digital Mortgage Platform addresses the inefficiencies of traditional mortgage systems by automating document collection, data review, and secure communication among all parties involved in the mortgage process. This innovation significantly reduces the loan processing cycle by approximately 50%, allowing MLOs to close loans more rapidly and efficiently. As a result, RealKey empowers MLOs to scale their operations in response to the increasing demand for mortgage applications, particularly during periods of heightened lending activity. The platform integrates seamlessly with existing point of sale and loan origination systems, providing a comprehensive digital mortgage processing experience for lenders, brokers, and their clients.

PittMoss

Seed Round in 2018
PittMoss LLC manufactures an innovative growing media called PittMoss, which consists of organic additives and recycled paper, catering to commercial greenhouses, nurseries, and home gardeners across the United States. The company also produces PittMoss Prime, a versatile soil amendment that can be combined with compost, existing soil blends, or native soil. Founded in 1994 and based in Ambridge, Pennsylvania, PittMoss focuses on sustainability and environmental responsibility, aiming to enhance soil health and improve gardening outcomes. The company's products reflect extensive research and development in the fields of gardening and soil science, establishing a strong presence in the growing media market.

Beta Hatch

Seed Round in 2018
Beta Hatch grows insect protein for animal feed. Nutrient balanced fertilizer is a sterile by-product of their process. Beta Hatch knows bugs better than anyone- they use their expertise in entomology to grow the most efficient and nutritious insects. They are currently farming mealworms from their urban farm in Seattle. They believe in changing food systems. Their goal is to develop the technology and knowledge that will make insects the next commodity crop.

Alpin

Angel Round in 2017
Alpin, Inc. develops a cloud identity management platform that allows users and companies to find and manage their cloud software. It also enables the users to discover cloud software, manage costs and renewals, security and compliance, and automates workflow. Alpin, Inc. was formerly known as Logrr, Inc. The company was incorporated in 2015 and is based in Boulder, Colorado. As of October 25, 2019, Alpin, Inc. operates as a subsidiary of Coreview.

OtoNexus Medical Technologies

Private Equity Round in 2017
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.

SHM Control

Seed Round in 2017
SHM Controls Inc. specializes in developing a smart touch-screen device that manages boilers and hot-water tanks for residential and commercial buildings, including schools and hospitals. Founded in 2011 and headquartered in Vancouver, Canada, the company addresses the rising costs of gas consumption in apartment buildings by offering a solution that allows users to monitor and control their heating systems remotely. The SHM Controller™ utilizes a predictive-adaptive algorithm and a mesh network of wireless sensors, enabling significant energy savings and reducing operating costs. Users can access the system via on-device controls or web and mobile applications, receiving alerts through email and text notifications. This innovative approach combines expertise from real estate, computer engineering, and HVAC technology to meet the market demand for efficient energy management solutions.

Blaze Bioscience

Series B in 2017
Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, that focuses on enhancing cancer surgery through innovative technologies. Founded in 2010, the company develops tumor paint products, including its lead candidate, BLZ-100, which combines a targeting peptide with a fluorescent dye. This product enables real-time visualization of cancer cells during surgery, allowing surgeons to differentiate between tumors and healthy tissue more effectively. The technology is applicable to various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcomas. By improving the detection of cancer cells, Blaze Bioscience aims to facilitate more precise surgical resections and ultimately enhance patient outcomes.

PainQx

Venture Round in 2017
PainQx is a diagnostic/software company that has developed a next generation approach to objectively measure pain in humans. The PainQx platform achieves this by assessing neural activity from a patient’s brain and processing and decoding the data through proprietary algorithms. The output is a scaled pain and neurological side effects biomarker that is directly correlated to a patient’s pain state. The PainQx system is currently being used as a clinical assessment tool by companies using pain as a primary or secondary clinical end point to measure their drug’s and/or device’s efficacy.

Waggit

Funding Round in 2017
Waggit offers a smart wearable collar and a mobile application designed to enhance the health and well-being of dogs. The wearable collar monitors critical health indicators, including vital signs, body positions, sleep patterns, activity levels, nutrition, location, and ambient temperature. By providing these insights, Waggit empowers dog owners to take a proactive approach to their pets' health, facilitating early detection of potential health issues. The comprehensive application is tailored to meet the needs of pet owners, making it easier to track and manage their dogs' health and lifestyle.

Art Analysis & Research

Series A in 2017
Art Analysis & Research Limited specializes in the technical investigation of paintings, offering a range of services that include pigment analysis, digital imaging, and the study of materials to establish attribution, condition, and dating of artworks. The company employs both technical art history and scientific methods, utilizing advanced techniques such as dendrochronology, isotope analysis, and radiocarbon dating. With a focus on artworks from various periods, including medieval and mid-twentieth century pieces, Art Analysis & Research combines extensive archival knowledge with modern analytical approaches. Founded in 2009 and based in Kingston Upon Thames, United Kingdom, the company is committed to maintaining high standards of professional expertise while providing fully confidential services.

Touchjet

Venture Round in 2017
Touchjet Pte. Ltd. is a technology company that specializes in manufacturing interactive Android projectors with a touch interface and wireless streaming capabilities. Founded in 2013 and headquartered in Singapore, with an additional office in San Francisco, the company offers products such as the Touchjet Pond Projector, which can transform any flat surface into a touchscreen. This projector is complemented by a digital stylus that functions as an infrared emitter for interactive use. Additionally, Touchjet provides a software platform that enhances cloud services and touchscreen interactivity, facilitating digital collaboration in settings like conference rooms and classrooms.

Zive

Seed Round in 2017
Zive, Inc. is a consumer software company headquartered in New York, specializing in the development of 'Kiwi for Gmail,' an email desktop application designed for Mac and Windows users. The latest version, Kiwi for Gmail 2.0, introduces a new toolbar that enhances multitasking capabilities and allows users to access G Suite applications, such as Docs and Slides, as desktop applications. Founded in 2013, Zive's team boasts over a decade of experience in software and consumer electronics design, with a strong emphasis on user-centered product development. The company's leadership includes individuals with substantial backgrounds in technology and venture funding, who have previously collaborated with recognized brands in the industry.

Phyllom Bioproducts

Venture Round in 2017
Phyllom BioProducts Corporation is a plant biotechnology company headquartered in Phoenix, Arizona, that specializes in developing and marketing biological insecticides. The company offers products such as boreGONE!, designed to combat the emerald ash borer in North American hardwood forests; beetleGONE!, which targets beetle species like the Japanese beetle on various plants; and grubGONE!, a granulated bio-insecticide for turf and ornamental applications. Phyllom is also focused on creating beetle control solutions for the agriculture and animal health sectors. Its clientele includes government agencies like the USDA and the US Park Service, as well as state governments, municipalities, and private foresters. The company markets its products through direct sales and partnerships with distributors. Phyllom BioProducts was established in 2012 and aims to provide effective and environmentally friendly solutions for managing invasive insect populations across multiple sectors.

Fairway America

Venture Round in 2017
Fairway America is a private equity and advisory firm based in Portland, Oregon, that focuses on commercial real estate asset-based investments within the middle market across the United States. Established in 1992, the firm aims to provide investors with access to the fragmented and opportunity-rich middle market by partnering with select real estate entrepreneurs. Fairway America offers essential operational support and capital to its Sponsor Partners, enabling them to develop and manage investments effectively. The firm specializes in delivering alternative real estate investment products to sophisticated investors, emphasizing sectors such as retail and self-storage. Through its strategic partnerships, Fairway America facilitates investment opportunities that may otherwise be difficult to access.

Phytelligence

Convertible Note in 2016
Phytelligence, Inc. is an agricultural biotechnology company that specializes in growing and providing high-quality plants and innovative solutions for growers, nurseries, and horticultural experts. Founded in 2012 and based in Pullman, Washington, the company offers a range of tissue-cultured plantlets, including varieties of pear, apple, cherry, grape, and strawberry, all free from diseases, viruses, and pests. Phytelligence also provides custom genetic analysis services to evaluate the genetic similarities and differences among closely related plant samples. Its advanced propagation and quality control processes ensure that clients receive genetically confirmed plants that are healthy and ready for planting, ultimately enhancing productivity and quality in crop production.

Picmonic

Series A in 2016
Picmonic Inc. operates an audiovisual learning platform designed to enhance memory retention and improve exam performance for students in various fields, particularly nursing and medicine. The platform transforms traditional textbook information into engaging visual stories, known as Picmonics, which utilize humor and memorable graphics to facilitate effective studying. Covering a wide range of subjects including pharmacology, microbiology, and anatomy, Picmonic also offers tools for users to learn, review, and quiz themselves, making the study process interactive and personalized. Founded in 2011 and based in Tempe, Arizona, Picmonic aims to foster a collaborative educational community where learners can create, share, and discover content that enhances academic and professional outcomes.

Lungpacer

Angel Round in 2016
Lungpacer Medical Inc. is a medical device company based in Vancouver, Canada, with an additional office in Exton, Pennsylvania. Founded in 2009, the company specializes in developing therapeutic solutions for critically ill patients who require mechanical ventilation. Its primary product, the Lungpacer DPT System, is a diaphragm pacing system designed to preserve and restore the strength of the diaphragm muscle. This innovative system utilizes the body's nervous system to stimulate the diaphragm, enabling repetitive exercises that help rebuild muscle strength and endurance. By addressing diaphragm muscle disuse atrophy, Lungpacer aims to improve the overall respiratory health of patients, facilitating better outcomes in critical care settings.

Bouxtie

Seed Round in 2016
Bouxtie [pronounced bow-tie] is transforming the way people give gifts and connect. With the Bouxtie application select from hundreds of top retail brands and instantly send a digital gift card right from your phone.

Curb

Convertible Note in 2016
Curb, Inc. is a technology company based in Austin, Texas, founded in 2012. It specializes in energy engagement software and home energy management solutions. Curb develops a mobile application and web interface that enables users to monitor their electricity usage, uncover home energy trends, and identify appliances that contribute significantly to energy costs. The platform also offers tips for energy savings and provides safety alerts related to electricity use. By consolidating these features in a single product, Curb empowers homeowners to take control of their energy consumption and manage their electricity bills more effectively.

Vispera

Seed Round in 2016
Vispera Information Technologies, founded in 2014 and headquartered in Istanbul, Turkey, specializes in image recognition and analytics tailored for the retail sector. The company offers proprietary technology that provides retailers and suppliers with critical insights to enhance performance at points of sale. Vispera's solutions enable clients to monitor in-store execution and make necessary adjustments through real-time data analysis. Key metrics offered by the platform include on-shelf availability, planogram compliance, and pricing accuracy. These services address significant issues within the retail industry, such as the annual losses attributed to poor on-shelf availability. By leveraging advanced image recognition technology, Vispera aims to transform retail operations, moving beyond being a simple vendor to becoming a comprehensive retail data analytics provider. The company's commitment to high accuracy and customer satisfaction has resulted in a growing client base, as competitors' clients increasingly turn to Vispera for their needs in retail execution and analytics.

Textile-Based Delivery

Venture Round in 2016
Textile-Based Delivery, Inc., operating under the name Nufabrx, focuses on developing and manufacturing fabrics that incorporate embedded medications and active ingredients. The company creates products such as bamboo pillowcases infused with tea tree oil and lavender, which release these substances during sleep. Nufabrx's innovative technologies allow for the sustained and controlled delivery of beneficial compounds through various textiles, enabling enhancements in performance, healing, and aesthetic qualities. Their offerings include a wide range of apparel and accessories, such as headbands, wristbands, socks, shirts, shorts, underwear, shoes, and swimwear. Founded in 2011, Textile-Based Delivery, Inc. is based in Seattle, Washington, with an additional office in Minneapolis, Minnesota.

UnaliWear

Series A in 2016
UnaliWear Inc., based in Austin, Texas, develops the Kanega watch, a multipurpose wearable designed for seniors to maintain independence and dignity. This discreet device offers features such as fall detection, medication reminders, and assistance for individuals who may wander, all through a voice-activated interface. The Kanega watch is equipped with various technologies, including cellular, Wi-Fi, GPS, and Bluetooth, allowing it to provide emergency support anywhere without the need for a smartphone. Its patented battery system ensures that the watch remains charged without requiring removal. Additionally, the device incorporates data-driven artificial intelligence to learn the user’s lifestyle, enabling it to offer predictive and preemptive assistance tailored to individual needs.

Safe-H2O

Seed Round in 2016
Safe H2O operates as a water bio detection company that provides pathogen test systems and data services. It engages in assisting water managers and water treatment service providers in reducing fatalities and illnesses related to waterborne pathogens and assuring the sustainability of water systems.

Resonance AI

Seed Round in 2016
Resonance AI specializes in the fields of artificial intelligence, analytics, and video streaming. Using advanced machine learning available, Resonance AI’s unmatched efficiency and accuracy enables quick decisions about content and talent grounded in real performance data. It was founded in 2013 and headquartered in Seattle, Washington.

Sisu Global Health

Seed Round in 2016
Sisu Global Health provides clinically proven, patented, high margin devices, starting with Hemafuse, a highly effective alternative to donor blood. With a simple push and pull of a handle, the device transfers blood from where it is pooled in internal bleeding to a blood bag: blood is salvaged and immediately re-transfused. Sisu achieved regulatory approval in Ghana and Kenya and Hemafuse and signed two distribution contracts. Founded in 2014 by Carolyn Yarina, Gillian Henker, and Katie Kirsch, Sisu Global Health is headquartered in Baltimore, Maryland.

Cone & Steiner

Venture Round in 2016
Cone & Steiner is a one-stop shop brimming indoors and out with fresh flowers and produce, dry goods, ice cream, and a curated selection of prepared foods. It features a unique twist on the corner store it features specialty, local, and staple goods, as well as a robust assortment of craft beers and fine wines.

Embera NeuroTherapeutics

Venture Round in 2016
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Reelsonar

Venture Round in 2016
ReelSonar, Inc. is a company that specializes in designing and developing innovative fishing technology. Its flagship product, the iBobber, is a castable fishfinder that utilizes sonar technology to locate fish at depths of up to 135 feet. The iBobber connects via Bluetooth to smartphones and tablets, allowing users to access various features such as GPS tagging of fishing hotspots, mapping waterbed contours, and monitoring water temperature. Additionally, the application includes functionalities like lunar calendar information, weather updates, Trip Logs, and Fish and Bite Alarms, enhancing the fishing experience. ReelSonar offers its products through various retail channels and online, serving customers in the United States, Canada, Europe, Asia, and beyond. Founded in 2012 and headquartered in Seattle, Washington, ReelSonar aims to improve fishing efficiency and enjoyment for anglers of all levels.

Precision Image Analysis

Venture Round in 2016
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Analyze

Venture Round in 2016
Analyze Corporation specializes in big data analytics and cybersecurity solutions, aiming to enhance organizational performance and customer privacy. Founded in 2013 and headquartered in Fairfax, Virginia, the company offers a suite of products designed for various industries. These include Clientell, a cloud-based SaaS tool for targeted marketing, and Donor Impact, which assists non-profit organizations in identifying potential donors. Additionally, Analyze develops Chi-Square, an open-source Linux distribution project, and Pin Drop PRO, a solution focused on retail location analytics. The company’s self-service platform enables clients to transform customer data into actionable insights, appending extensive data characteristics to enhance market segmentation and optimize return on investment.

First Light Diagnostics

Venture Round in 2016
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.

iHealthHome

Venture Round in 2016
iHealthHome, LLC specializes in providing an in-home monitoring and communication system tailored for professional caregivers. Established in 2009 and based in Honolulu, Hawaii, the company offers a comprehensive data collection device that securely interfaces with web-based software, creating an integrated system for effective care management. Its flagship product, iHealthNavigator, equips clinical teams with tools to automate daily care management tasks and enhance client care coordination. The platform is designed for a variety of users, including home care agencies, complex care coordinators, residential care homes, senior living communities, and family caregivers. By connecting the entire care team and integrating workflows, iHealthHome enables secure digital record-keeping on mobile devices and facilitates the monitoring of patients’ health through sensors and wearable devices. The company operates as a subsidiary of Ho'okele Health Innovations, LLC.

Indow

Venture Round in 2016
Indow Windows provides people with comfort and quiet while helping them achieve financial and environmental harmony. Indow Windows are window inserts that press into place on the inside of existing window frames with no nails, screws, or adhesives. It gives all of the energy-saving benefits of double pane windows but has the bonus feature of reducing the noise coming in from outside by 50% or more. An Indow Window is made of a sheet of acrylic glazing edged with our patented Compression Tube. The simple yet elegant design creates a very low profile when installed so that the product disappears and its own Home's beauty shines through. Indow Windows was founded by CEO, Sam Pardue with the mission of maximizing carbon reductions and customer comfort and savings.

Operative Experience

Venture Round in 2016
Operative Experience Inc. specializes in the manufacture of simulation-based training systems for surgical and emergency medical services (EMS) applications worldwide. The company provides a range of training solutions, including emergency obstetrics surgical systems that feature various simulators for skills such as fetal extraction and hemorrhage control. Additionally, Operative Experience offers training systems for emergency cranial and thoracic surgeries, along with the MasCal Trauma Training System, which consists of ruggedized simulators designed to prepare medical personnel for combat-related injuries. The organization aims to improve training effectiveness and retention while simultaneously reducing costs, contributing to lower surgical mortality rates in both combat and civilian settings. Established in 2008 and based in North East, Maryland, Operative Experience is committed to enhancing medical training, particularly in regions with limited resources.

TranscribeMe

Venture Round in 2016
TranscribeMe Inc. develops a mobile audio transcription platform that converts audio and video content into searchable and shareable text. Founded in 2011, the company is headquartered in San Francisco, California, and utilizes proprietary micro-tasking technology to deliver high-quality transcriptions, including speaker identification and time coding. Its services cater to various sectors, including medical, market research, education, and corporate environments, enabling clients such as medical professionals, conference organizers, writers, podcasters, and academics to analyze and monetize their audio content. By processing audio in parallel, TranscribeMe effectively handles complex recordings with multiple speakers and overlapping conversations, ensuring accurate and efficient transcription.

Perkville

Venture Round in 2016
Perkville is a leading retention and referral solution for the health, fitness, salon, spa, and retail industries. Their rewards program integrates directly with POS or scheduling systems and can be custom-tailored for every business. Featured in businesses around the world, the Perkville system can drive referrals, reward clients for return visits and make purchases, and even generate social media posts. It was founded in 2010 and is headquartered in Oakland, California.

Blaze Bioscience

Venture Round in 2016
Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, that focuses on enhancing cancer surgery through innovative technologies. Founded in 2010, the company develops tumor paint products, including its lead candidate, BLZ-100, which combines a targeting peptide with a fluorescent dye. This product enables real-time visualization of cancer cells during surgery, allowing surgeons to differentiate between tumors and healthy tissue more effectively. The technology is applicable to various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcomas. By improving the detection of cancer cells, Blaze Bioscience aims to facilitate more precise surgical resections and ultimately enhance patient outcomes.

LumiThera

Venture Round in 2016
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Established in 2013, the company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LED) and laser technologies to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. By employing low-level light therapy, LumiThera aims to slow or halt the progression of blinding diseases, enhance visual acuity and contrast sensitivity, and reduce central drusen volume, ultimately providing healthcare providers with effective treatment options for their patients.

Viakoo

Venture Round in 2016
Viakoo, Inc. offers a software-as-a-service (SaaS) application that provides advisories about problems in video network infrastructure. Its products include Viakoo Preemptive, Viakoo Predictive, and Viakoo Predictive OP, which enables users to discover, map, and instrument their video network; and provides performance trending information of video surveillance infrastructure, the dashboard status, bulletins, summary reports, real-time detection, remote alerting, and a troubleshooting database. The company also provides customer support and diagnostics, troubleshooting assistance, and professional services. Viakoo, Inc. was incorporated in 2013 and is based in Mountain View, California.

Savara

Series C in 2016
Savara Inc. is a biopharmaceutical company based in Austin, Texas, specializing in rare respiratory diseases. Its primary product candidate, Molgradex, is an inhaled granulocyte-macrophage colony-stimulating factor currently in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Additionally, Molgradex is being evaluated in Phase IIa trials for nontuberculous mycobacterial (NTM) lung infections and cystic fibrosis patients with chronic NTM infections. Savara is also developing AeroVanc, an inhaled vancomycin, which is in Phase III trials for treating methicillin-resistant Staphylococcus aureus (MRSA) lung infections in cystic fibrosis patients. The company aims to expand its pipeline through strategic partnerships and product acquisitions, including a recent acquisition of a combination antibiotic that targets drug-resistant pathogens. Savara's management team has extensive experience in orphan drug development and is focused on addressing unmet medical needs in the field of pulmonary medicine.

Linqto

Seed Round in 2016
Linqto is a financial technology company that facilitates liquidity in private securities markets, enabling founders, venture capitalists, and employees to access early returns without waiting for an initial public offering or trade sale. By allowing companies to remain private for longer periods while still providing ongoing liquidity, Linqto supports a more flexible investment environment. The platform connects accredited investors with a diverse range of private companies across various sectors, helping them identify firms that are well-positioned for successful IPOs. Through its technology-driven approach, Linqto aims to democratize access to private investments, similar to how traditional brokerage firms have made public equity trading more accessible.

Monitor Mask

Venture Round in 2016
Monitor Mask Inc. is a Seattle-based medical device company that specializes in manufacturing and selling face mask solutions designed for CO2 sampling in sidestream capnography, particularly during sedation anesthesia. Founded in 2012, the company primarily serves hospitals and ambulatory surgery centers, catering to various medical environments such as operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. The initial product, the M1 Capnography Mask, inspired the development of the CapnoVue face mask series, which aims to enhance patient safety and streamline clinical workflows. As of May 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

LumiThera

Venture Round in 2016
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Established in 2013, the company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LED) and laser technologies to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. By employing low-level light therapy, LumiThera aims to slow or halt the progression of blinding diseases, enhance visual acuity and contrast sensitivity, and reduce central drusen volume, ultimately providing healthcare providers with effective treatment options for their patients.

Embera NeuroTherapeutics

Venture Round in 2016
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Bouxtie

Venture Round in 2016
Bouxtie [pronounced bow-tie] is transforming the way people give gifts and connect. With the Bouxtie application select from hundreds of top retail brands and instantly send a digital gift card right from your phone.

Tether Technologies

Series A in 2016
Tether Technologies, Inc. specializes in preemptive key loss technology aimed at enhancing security for individuals and businesses while preventing key loss incidents and their associated costs. The company's flagship product, the electronic key tether (ekt), preemptively locates keys before they are lost and ensures they remain within a 15-step radius of the user. This innovative solution is designed to integrate seamlessly into existing key control programs and is suitable for various sectors, including security, property management, hospitality, healthcare, and law enforcement. Founded in 2010 and headquartered in Seattle, Washington, Tether Technologies offers a reliable and scalable alternative to traditional key management systems, which often respond only after keys are lost, leading to expensive rekeying processes and potential security breaches.

WattIQ

Venture Round in 2016
WattIQ, originally founded as Ibis Networks in 2013, specializes in energy management solutions aimed at reducing energy waste from electrical devices. The company addresses the significant financial losses businesses incur from devices that consume power when not in active use. WattIQ's product line includes advanced networked smart plugs designed for scalability and reliability, particularly in higher education and K-12 institutions. Recent expansions of their offerings focus on asset utilization and condition monitoring, allowing businesses to leverage energy consumption data to optimize resource sharing, minimize unnecessary equipment purchases, identify operational bottlenecks, and lower their carbon footprint. With a commitment to enhancing asset management and sustainability, WattIQ empowers organizations to make informed decisions regarding energy use and procurement. The company operates from its headquarters in Honolulu, Hawaii, with additional locations in California and Washington.

Precision Image Analysis

Venture Round in 2016
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.

KPI Therapeutics

Venture Round in 2015
KPI Therapeutics, Inc. is a Seattle-based company focused on developing therapies for unmet medical needs in autoimmunity and chronic pain. Founded in 2013, it specializes in creating drug candidates such as dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases like lupus, along with CSP conopeptide for chronic pain management. The company collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance its research and development efforts. KPI Therapeutics aims to accelerate the progression of promising drug candidates through the critical translational stage of development, ultimately improving access to innovative treatments for patients.

iHealthHome

Venture Round in 2015
iHealthHome, LLC specializes in providing an in-home monitoring and communication system tailored for professional caregivers. Established in 2009 and based in Honolulu, Hawaii, the company offers a comprehensive data collection device that securely interfaces with web-based software, creating an integrated system for effective care management. Its flagship product, iHealthNavigator, equips clinical teams with tools to automate daily care management tasks and enhance client care coordination. The platform is designed for a variety of users, including home care agencies, complex care coordinators, residential care homes, senior living communities, and family caregivers. By connecting the entire care team and integrating workflows, iHealthHome enables secure digital record-keeping on mobile devices and facilitates the monitoring of patients’ health through sensors and wearable devices. The company operates as a subsidiary of Ho'okele Health Innovations, LLC.

Bouxtie

Seed Round in 2015
Bouxtie [pronounced bow-tie] is transforming the way people give gifts and connect. With the Bouxtie application select from hundreds of top retail brands and instantly send a digital gift card right from your phone.

Indow

Series B in 2015
Indow Windows provides people with comfort and quiet while helping them achieve financial and environmental harmony. Indow Windows are window inserts that press into place on the inside of existing window frames with no nails, screws, or adhesives. It gives all of the energy-saving benefits of double pane windows but has the bonus feature of reducing the noise coming in from outside by 50% or more. An Indow Window is made of a sheet of acrylic glazing edged with our patented Compression Tube. The simple yet elegant design creates a very low profile when installed so that the product disappears and its own Home's beauty shines through. Indow Windows was founded by CEO, Sam Pardue with the mission of maximizing carbon reductions and customer comfort and savings.

Abom

Convertible Note in 2015
Abom, Inc. is a company based in Portland, Oregon, founded in 2014, specializing in the design and development of snow goggles featuring active anti-fog technology. The innovative goggles utilize a metal film embedded in the lens that heats up to prevent fogging, enhancing visibility and performance for users in snowy conditions. Abom brings together a team of inventors, scientists, and designers dedicated to creating advanced gear that addresses common challenges faced by outdoor enthusiasts, thereby improving their overall experience.

Tilting Motor Works

Series A in 2015
Tilting Motor Works, Inc. specializes in developing leaning three-wheel conversion solutions for motorcycles, enhancing stability and performance. Founded in 2008 and based in Snohomish, Washington, the company offers a patented conversion system that replaces the front fork and front wheel with a new assembly that maintains the motorcycle's ability to lean into turns. This innovative design provides motorcycle riders with the stability of a three-wheeled vehicle while preserving the handling characteristics of a two-wheeler. The conversion includes various components such as linkage, shocks, wheels, tires, brakes, and mounting hardware, enabling both seasoned riders to continue enjoying motorcycling and new riders to gain confidence on larger bikes. The performance benefits include improved traction and braking, appealing to enthusiasts who value high-speed cornering capabilities.

Monitor Mask

Series A in 2015
Monitor Mask Inc. is a Seattle-based medical device company that specializes in manufacturing and selling face mask solutions designed for CO2 sampling in sidestream capnography, particularly during sedation anesthesia. Founded in 2012, the company primarily serves hospitals and ambulatory surgery centers, catering to various medical environments such as operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. The initial product, the M1 Capnography Mask, inspired the development of the CapnoVue face mask series, which aims to enhance patient safety and streamline clinical workflows. As of May 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

LumiThera

Series A in 2015
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Established in 2013, the company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LED) and laser technologies to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. By employing low-level light therapy, LumiThera aims to slow or halt the progression of blinding diseases, enhance visual acuity and contrast sensitivity, and reduce central drusen volume, ultimately providing healthcare providers with effective treatment options for their patients.

First Light Diagnostics

Series A in 2015
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.

Precision Image Analysis

Series B in 2015
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.

Embera NeuroTherapeutics

Venture Round in 2015
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Acceleration Systems

Venture Round in 2015
Acceleration Systems LLC specializes in providing cloud-based bandwidth acceleration, optimization, and encryption services. Founded in 2012 and based in Northfield, Ohio, the company caters to individuals and small to medium-sized businesses across various sectors, including energy, construction, healthcare, education, and transportation. Its offerings encompass internet technology, software development, application optimization, and security technology. The company's optimization platform enhances internet performance, ensuring improved efficiency and security for its clients, allowing them to better manage network demands. With a team of experienced professionals from diverse backgrounds, Acceleration Systems is dedicated to addressing the global challenges associated with bandwidth limitations.

Aqueduct Critical Care

Venture Round in 2015
Aqueduct Critical Care addresses the critical care problem of managing inter-cranial pressure. Its working prototypes demonstrate the ability to allow the patient to move, and minimize attention from nursing staff. Aqueduct Critical Care was founded in 2013 and is based in Bothell, Washington.

20/20 GeneSystems

Series A in 2015
20/20 GeneSystems Inc. is a biotechnology company based in Rockville, Maryland, focused on developing and commercializing diagnostic tests for the early detection of cancer. The company offers several products, including PAULA’s Test, a blood test for lung cancer detection, and OneTest, which screens for multiple cancer types, such as lung, liver, and pancreatic cancers. Additionally, 20/20 provides BioCheck, a detection kit for screening suspicious powders, and Layered ImmunoHistoChemistry, which predicts the efficacy of targeted cancer therapies. The firm also offers CoronaCheck Tests, specializing in COVID-19 antibody testing. With a commitment to reducing cancer mortality, 20/20 GeneSystems employs advanced biomarker technologies and collaborates with various health agencies and organizations to enhance cancer diagnostics and promote personalized medicine.

Building Energy

Convertible Note in 2015
Building Energy Inc., headquartered in Portland, Oregon, specializes in developing cloud-based solutions for managing energy disclosure data and compliance in the built environment. The company offers a secure platform that integrates data from various sources, enabling significant improvements in building energy efficiency. Its services include data standardization, management, and compliance solutions tailored for local governments, energy companies, large portfolio managers, and individual building owners. By providing a comprehensive ecosystem of data and applications, Building Energy Inc. aims to enhance decision-making processes and promote better practices within the entire built environment, from design and finance to operation and management. Established in 2012, the company is committed to fostering a trusted network of building data to drive improved outcomes for its clients.

Safe-H2O

Seed Round in 2015
Safe H2O operates as a water bio detection company that provides pathogen test systems and data services. It engages in assisting water managers and water treatment service providers in reducing fatalities and illnesses related to waterborne pathogens and assuring the sustainability of water systems.

Crowd Mics

Seed Round in 2015
Crowd Mics LLC, founded in 2014 and based in Mesa, Arizona, has developed a mobile application that enhances audience interaction during live events. The app transforms audience members' iOS and Android devices into wireless microphones, allowing them to speak directly into their phones to be heard over the sound system. In addition to this innovative feature, Crowd Mics offers text commenting and live polling capabilities, which facilitate increased engagement and enable participants to express their viewpoints effectively. The application aims to empower audiences, making them active contributors in various event settings.

OtoSense

Series A in 2015
OtoSense, Inc. is an infrastructure software company specializing in deep-learning sound recognition technology that transforms machine sounds and vibrations into actionable insights. Their platform operates at the edge, allowing for real-time sound detection on standard devices connected to scalable cloud software. OtoSense also offers a mobile application that translates various sounds, such as alarms and doorbells, into visual and tactile alerts, enhancing accessibility for users. Founded in 2013 and located in Palo Alto, California, the company provides acoustic monitoring evaluation kits and serves a diverse range of applications, from elderly monitoring to battlefield threat identification. OtoSense has made significant inroads in the automotive sector through partnerships, enabling early diagnosis of machinery anomalies and optimizing operational efficiencies across various industries where sound plays a crucial role. As of 2018, OtoSense operates as a subsidiary of Analog Devices, Inc.

OtoNexus Medical Technologies

Private Equity Round in 2015
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.

Social Standards

Seed Round in 2015
Social Standards, Inc. develops market research tools to discover and deliver actionable business insights with authentic analysis of social data. Its tool provide consumer voice measurement and marketing insights for beverage alcohol, beauty, personal care, food and beverage, quick serve restaurants, and other industries. Social Standards, Inc. was formerly known as BarTrendr, Inc. and changed its name to Social Standards, Inc., in July 2016. The Company was incorporated in 2011 and is based in Oakland, California

Abom

Series A in 2015
Abom, Inc. is a company based in Portland, Oregon, founded in 2014, specializing in the design and development of snow goggles featuring active anti-fog technology. The innovative goggles utilize a metal film embedded in the lens that heats up to prevent fogging, enhancing visibility and performance for users in snowy conditions. Abom brings together a team of inventors, scientists, and designers dedicated to creating advanced gear that addresses common challenges faced by outdoor enthusiasts, thereby improving their overall experience.

DecisionNext

Seed Round in 2015
DecisionNext, Inc. offers a cloud-based predictive analytics platform tailored for commodities-driven businesses, providing industry-specific insights that assist users in making informed decisions about production and sales locations. The company serves a diverse clientele across sectors such as minerals, agribusiness, fishing, forestry, oil, and gas. Established in 2013 and headquartered in San Francisco, California, with an additional office in Brisbane, Australia, DecisionNext focuses on enhancing end-to-end performance through its solutions, which include commodity price forecasting, purchasing and product mix optimization, capacity optimization, and pricing and promotion strategies. By integrating these optimizations into a cohesive system, DecisionNext aims to deliver significant value to its customers.

Acceleration Systems

Series A in 2015
Acceleration Systems LLC specializes in providing cloud-based bandwidth acceleration, optimization, and encryption services. Founded in 2012 and based in Northfield, Ohio, the company caters to individuals and small to medium-sized businesses across various sectors, including energy, construction, healthcare, education, and transportation. Its offerings encompass internet technology, software development, application optimization, and security technology. The company's optimization platform enhances internet performance, ensuring improved efficiency and security for its clients, allowing them to better manage network demands. With a team of experienced professionals from diverse backgrounds, Acceleration Systems is dedicated to addressing the global challenges associated with bandwidth limitations.

Embera NeuroTherapeutics

Series A in 2015
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

KiwiCo

Venture Round in 2015
KiwiCo sparks creativity in kids and saves time for busy parents by providing all of the inspiration and materials necessary for hours of imaginative play and learning. With monthly deliveries of activities designed to help kids discover, explore, and create things in the world around them, KiwiCo brings hands-on fun right to the door. It was founded in 2011 and is headquartered in Mountian View, California.

Viakoo

Venture Round in 2015
Viakoo, Inc. offers a software-as-a-service (SaaS) application that provides advisories about problems in video network infrastructure. Its products include Viakoo Preemptive, Viakoo Predictive, and Viakoo Predictive OP, which enables users to discover, map, and instrument their video network; and provides performance trending information of video surveillance infrastructure, the dashboard status, bulletins, summary reports, real-time detection, remote alerting, and a troubleshooting database. The company also provides customer support and diagnostics, troubleshooting assistance, and professional services. Viakoo, Inc. was incorporated in 2013 and is based in Mountain View, California.

KPI Therapeutics

Series A in 2015
KPI Therapeutics, Inc. is a Seattle-based company focused on developing therapies for unmet medical needs in autoimmunity and chronic pain. Founded in 2013, it specializes in creating drug candidates such as dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases like lupus, along with CSP conopeptide for chronic pain management. The company collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance its research and development efforts. KPI Therapeutics aims to accelerate the progression of promising drug candidates through the critical translational stage of development, ultimately improving access to innovative treatments for patients.

Kineta

Series B in 2015
Kineta, Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing immunology-based therapies targeting oncology, neuroscience, and virology. The company is advancing several innovative treatments, including KCP-506, a non-opioid therapeutic for chronic pain, and LHF-535, an oral antiviral for Lassa and other arenaviruses, which works by inhibiting viral entry and replication. Additionally, Kineta is exploring RIG-I and VISTA drug development programs aimed at reprogramming the immune system to combat cancer. Founded in 2007, Kineta has established strategic partnerships with major pharmaceutical firms to enhance its research and development efforts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.